Clinical Trial Update: Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial investigating potential adrenal suppression after DSXS treatment in patients with atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• DSXS

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Dermatitis, Atopic | Phase 2 | Status: COMPLETED | Results posted: 2018-12-07